AI-generated summary
The authors ran network meta-analyses of randomized trials comparing non-surgical treatments for androgenetic alopecia, separately for men (30 trials) and women (10 trials). They ranked platelet-rich plasma and low-level laser therapy highest for men and low-level laser therapy highest for women, with evidence quality judged low. The authors state that newer treatments need further validation in future randomized trials.
- Who or what was studied
- Men and women with androgenetic alopecia enrolled in randomized controlled trials of non-surgical monotherapies
- Limits stated in the abstract
- The authors judged the evidence quality of the highest ranked therapies to be low, and the newer treatments need further validation by future randomized trials.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on tandfonline.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a review: what to check before relying on this kind of research.
Terms in this paper: Androgenetic alopecia, Low-level laser therapy, Systematic review, Meta-analysis, Laser. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.